HealthQuill Articles by: HealthQuill
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Drugs Pharma Research

Study links gestational NSAID use to risk of childhood chronic kidney disease

HQ Team December 28, 2024: A study from Taiwan links the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy, with a potential risk

Read More
Health Medical Research

Study reveals early signs of Multiple Sclerosis in children

Bharti Jayshankar December 28, 2024: A recent research reveals that certain symptoms precede a diagnosis of multiple sclerosis (MS) in pediatric patients. The

Read More
A 56-year-old woman from China's Guangdong province died on March 16 after being infected with avian influenza, AH3N8, sparking the world's most populous nation to enforce control and preventive measures.
Health Medical

Mutations in severe H5N1 bird flu infection in humans worrisome: CDC

Bharti Jayshankar December 28, 2024: The Centers for Disease Control and Prevention (CDC) has identified mutations in genetic sequences from a patient in

Read More
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Health Medical

Sleeping pills show promise in reducing Alzheimer’s proteins

HQ Team December 28, 2024: Research has shown a potential connection between the progression of Alzheimer’s disease in people who take sleeping pills.

Read More
The European Union regulators have greenlighted AstraZeneca’s drug to treat an advanced form of non-small cell lung cancer after it reduced the death rate by 84%.
Drugs Medical Pharma

EU greenlights AstraZeneca’s non-small cell lung cancer drug

The European Union regulators have greenlighted AstraZeneca’s drug to treat an advanced form of non-small cell lung cancer after it reduced the death

Read More
Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s damaged blood vessel after a traumatic injury.
Drugs Health Medical Pharma

Humacyte’s tissue-engineered blood vessel for vascular trauma gets nod

Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s

Read More
fizer Inc.’s combination drug to treat a type of metastatic colorectal cancer has been approved by the US drug regulator, according to a company statement.
Drugs Medical Pharma

Pfizer’s drug to treat metastatic colorectal cancer gets US approval

fizer Inc.’s combination drug to treat a type of metastatic colorectal cancer has been approved by the US drug regulator, according to a

Read More
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six years and older, according to a statement from the company.
Drugs Health Medical Research

Vertex gets US regulator’s nod for extended use of cystic fibrosis drug

Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six

Read More
Danish pharmaceutical company Novo Nordisk’s combination drug achieved a 22.7% weight-loss reduction compared to a dummy drug during end-stage trials, according to a statement.
Uncategorized

Novo Nordisk says its drug CargiSema cuts body weight by 22.7% in adults

Danish pharmaceutical company Novo Nordisk’s combination drug achieved a 22.7% weight-loss reduction compared to a dummy drug during end-stage trials, according to a

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Health Pharma

Ionis Pharma’s drug to treat rare genetic disease gets US regulator’s nod 

The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia

Read More